Dimitris Boufidis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Dimitris Boufidis has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Raghav Garg
Department of Neurology University of Pennsylvania Philadelphia Pennsylvania USA
3 shared publications - Daniel Kacy Cullen
University of Pennsylvania
2 shared publications - Flavia Vitale
Department of Bioengineering University of Pennsylvania Philadelphia Pennsylvania USA
2 shared publications - Andrew G. Richardson
Department of Neurosurgery, University of Pennsylvania, Philadelphia, USA
1 shared publication - Bita Soltan Mohammadlou
A.J. Drexel Nanomaterials Institute and Department of Materials Science and Engineering Drexel University Philadelphia Pennsylvania USA
1 shared publication Charles‐Antoine Assenmacher
Comparative Pathology Core Department of Pathobiology School of Veterinary Medicine University of Pennsylvania Philadelphia Pennsylvania USA
1 shared publication
Latest Publications
- Open Access
- 25 September 2026
- Published by Wiley in Advanced Materials
- Vol. 38 (63) , e75137
Soft and Transient Bioelectronics Enabled by Polymer‐Free Ti 3 C 2 T x MXene Hydrogels
Implantable bioelectronics for acute neural applications must combine tissue‐like mechanics with high electrochemical performance while enabling safe biodegradation to avoid risks associated with explant surgeries. Here, we present MXgel bioelectronics, a soft and fully transient hydrogel platform that enables high‐fidelity electrophysiological recordings and effective stimulation with programmable degradation under physiological conditions. The platform employs polymer‐free Ti 3 C 2 T x MXene hydrogels (MXgel) that achieve exceptional electrical conductivities (hydrated: 790 ± 150 S m −1 , freeze‐dried: 4420 ± 576 S m −1 ). Integrated on biodegradable gelatin‐based substrates, MXgel bioelectronics exhibit low electrochemical impedance (1.06 ± 0.37 kΩ at 1 kHz), 25‐fold higher cathodic charge storage (207.1 ± 48.8 mC cm −2 ), and 10‐fold greater charge injection capacity (0.24 ± 0.08 mC cm −2 ) than conventional clinical electrodes. We demonstrate that these properties enable cortical and peripheral neural recordings with ∼60 dB signal‐to‐noise ratio and effective neuromodulation. Moreover, MXgel bioelectronics undergo safe degradation under physiological conditions with predictable and tunable kinetics. Importantly, MXgel bioelectronics do not trigger severe foreign body reaction, and their degradation byproducts do not accumulate in the body, confirming safe systemic clearance. Together, these results establish MXgel bioelectronics as a clinically relevant platform for soft, high‐performance, and transient neural interfaces.
- 25 September 2026
- Published by Wiley in Advanced Materials
- Vol. 38 (63) , e75137
Open AccessSoft and Transient Bioelectronics Enabled by Polymer‐Free Ti 3 C 2 T x MXene Hydrogels
Implantable bioelectronics for acute neural applications must combine tissue‐like mechanics with high electrochemical performance while enabling safe biodegradation to avoid risks associated with explant surgeries. Here, we present MXgel bioelectronics, a soft and fully transient hydrogel platform that enables high‐fidelity electrophysiological recordings and effective stimulation with programmable degradation under physiological conditions. The platform employs polymer‐free Ti 3 C 2 T x MXene hydrogels (MXgel) that achieve exceptional electrical conductivities (hydrated: 790 ± 150 S m −1 , freeze‐dried: 4420 ± 576 S m −1 ). Integrated on biodegradable gelatin‐based substrates, MXgel bioelectronics exhibit low electrochemical impedance (1.06 ± 0.37 kΩ at 1 kHz), 25‐fold higher cathodic charge storage (207.1 ± 48.8 mC cm −2 ), and 10‐fold greater charge injection capacity (0.24 ± 0.08 mC cm −2 ) than conventional clinical electrodes. We demonstrate that these properties enable cortical and peripheral neural recordings with ∼60 dB signal‐to‐noise ratio and effective neuromodulation. Moreover, MXgel bioelectronics undergo safe degradation under physiological conditions with predictable and tunable kinetics. Importantly, MXgel bioelectronics do not trigger severe foreign body reaction, and their degradation byproducts do not accumulate in the body, confirming safe systemic clearance. Together, these results establish MXgel bioelectronics as a clinically relevant platform for soft, high‐performance, and transient neural interfaces.
- Open Access
- 18 August 2025
- Published by Wiley in Advanced Materials Interfaces
- Vol. 12 (20)
Astrocyte Interactions With Ti 3 C 2 T x MXene Flakes: Insights Into Viability, Morphology, and Functionality
Astrocytes, the most abundant cell type in the brain, are increasingly recognized as active regulators of neuronal function and potential therapeutic targets. Two‐dimensional MXenes, such as titanium carbide (Ti 3 C 2 T x ), hold promise for neural interfaces and bioelectronic applications owing to their favorable electrochemical properties, but their compatibility with glial cells has yet to be investigated. Here, the first systematic evaluation of astrocyte–MXene interactions is reported by exposing cortical rat astrocytes to varying concentrations of Ti 3 C 2 T x in aqueous dispersions. Phase contrast and scanning electron microscopy showed individual flakes and larger aggregates on astrocyte membranes with no detectable damage. Cytotoxicity assays demonstrated robust astrocyte viability, morphological analysis indicated no significant changes in cell structure, and calcium imaging revealed no changes in spontaneous Ca 2 ⁺ activity between control and Ti 3 C 2 T x ‐treated cultures. These findings establish a foundation for the integration of Ti 3 C 2 T x into next‐generation neural interfaces while underscoring the need for further exploration of MXene‐based tools for astrocyte‐targeted neuromodulation.
- 18 August 2025
- Published by Wiley in Advanced Materials Interfaces
- Vol. 12 (20)
Open AccessAstrocyte Interactions With Ti 3 C 2 T x MXene Flakes: Insights Into Viability, Morphology, and Functionality
Astrocytes, the most abundant cell type in the brain, are increasingly recognized as active regulators of neuronal function and potential therapeutic targets. Two‐dimensional MXenes, such as titanium carbide (Ti 3 C 2 T x ), hold promise for neural interfaces and bioelectronic applications owing to their favorable electrochemical properties, but their compatibility with glial cells has yet to be investigated. Here, the first systematic evaluation of astrocyte–MXene interactions is reported by exposing cortical rat astrocytes to varying concentrations of Ti 3 C 2 T x in aqueous dispersions. Phase contrast and scanning electron microscopy showed individual flakes and larger aggregates on astrocyte membranes with no detectable damage. Cytotoxicity assays demonstrated robust astrocyte viability, morphological analysis indicated no significant changes in cell structure, and calcium imaging revealed no changes in spontaneous Ca 2 ⁺ activity between control and Ti 3 C 2 T x ‐treated cultures. These findings establish a foundation for the integration of Ti 3 C 2 T x into next‐generation neural interfaces while underscoring the need for further exploration of MXene‐based tools for astrocyte‐targeted neuromodulation.
- Top Cited PapersOpen Access
- 21 February 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-17
Bio-inspired electronics: Soft, biohybrid, and “living” neural interfaces
Neural interface technologies are increasingly evolving towards bio-inspired approaches to enhance integration and long-term functionality. Recent strategies merge soft materials with tissue engineering to realize biologically-active and/or cell-containing living layers at the tissue-device interface that enable seamless biointegration and novel cell-mediated therapeutic opportunities. This review maps the field of bio-inspired electronics and discusses key recent developments in tissue-like and regenerative bioelectronics, from soft biomaterials and surface-functionalized bioactive coatings to cell-containing ‘biohybrid’ and ‘all-living’ interfaces. We define and contextualize key terminology in this emerging field and highlight how biological and living components can bridge the gap to clinical translation.
- 21 February 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-17
Top Cited PapersOpen AccessBio-inspired electronics: Soft, biohybrid, and “living” neural interfaces
Neural interface technologies are increasingly evolving towards bio-inspired approaches to enhance integration and long-term functionality. Recent strategies merge soft materials with tissue engineering to realize biologically-active and/or cell-containing living layers at the tissue-device interface that enable seamless biointegration and novel cell-mediated therapeutic opportunities. This review maps the field of bio-inspired electronics and discusses key recent developments in tissue-like and regenerative bioelectronics, from soft biomaterials and surface-functionalized bioactive coatings to cell-containing ‘biohybrid’ and ‘all-living’ interfaces. We define and contextualize key terminology in this emerging field and highlight how biological and living components can bridge the gap to clinical translation.